Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Emgality
Pharma
After Lilly accord, Organon's CEO is hungry to ink more deals
After picking up European rights to two migraine drugs from Eli Lilly, Organon is hungry to ink more deals.
Fraiser Kansteiner
Feb 16, 2024 8:50am
Lilly's Branchburg production site in trouble with the FDA again
Jan 22, 2024 11:35am
Organon is taking over marketing of two Lilly meds in Europe
Dec 18, 2023 10:15am
Teva, Eli Lilly agree to dismiss one of Teva's patent cases
Nov 28, 2023 12:07pm
Judge sides with Lilly in patent case, overturning $177M verdict
Sep 27, 2023 11:05am
Lilly's Emgality fails to top Pfizer's Nurtec in migraine trial
Jun 20, 2023 3:24pm